Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Vaccines|May 7, 2025
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based AnalysisLin Yuan, Madison Stoddard, Sharanya Sarkar, et al.
Plos One|November 4, 2014
Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell linesDenise L Driscoll, Arijit Chakravarty, Doug Bowman, et al.
Plos One|April 28, 2021
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike proteinDebra Van Egeren, Alexander Novokhodko, Madison Stoddard, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2013
Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinaseSanthosh Palani, Mayankbhai Patel, Jessica Huck, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|March 2, 2019
Association Between Serum Prealbumin Level and Outcomes in Prevalent Kidney Transplant RecipientsAbduzhappar Gaipov, Christopher D Jackson, Manish Talwar, et al.
Frontiers in Drug Delivery|August 21, 2025
On a model-based approach to improve intranasal spray targeting for respiratory viral infectionsMohammad Mehedi Hasan Akash, Yueying Lao, Pallavi A Balivada, et al.
British Journal of Clinical Pharmacology|April 27, 2025
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect levelLin Yuan, Meghana Kulkarni, Evan Chiswick, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Decoding the mechanophysiology for inhaled onset of smallpox with model-based implications for mpox spreadMohammad Yeasin, Mohammad Mehedi Hasan Akash, Abir Malakar, et al.
Drug Metabolism Letters|February 4, 2014
Preclinical drug metabolism and pharmacokinetics, and prediction of human pharmacokinetics and efficacious dose of the investigational Aurora A kinase inhibitor alisertib (MLN8237)Johnny J Yang, Yu Li, Arijit Chakravarty, et al.
Frontiers in Public Health|December 19, 2022
No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loadsDebra Van Egeren, Madison Stoddard, Abir Malakar, et al.
Pageof 5